Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Scott Sproul
Institution:
Sangamo BioSciences (United States)
Observed institutions:
Genentech,
Sangamo BioSciences (United States)
OpenAlex ID:
A5079503723
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
2015
·
Rajiv Sharma
, Xavier M. Anguela
, et al.
·
Blood
·
296
Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
2018
·
Kanut Laoharawee
, Russell C. DeKelver
, et al.
·
Molecular Therapy
·
125
PDF
ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome
2018
·
Li Ou
, Russell C. DeKelver
, et al.
·
Molecular Therapy
·
84
PDF
AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction
2020
·
Makiko Yasuda
, Marshall W. Huston
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
57
PDF
ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice
2021
·
Silvere Pagant
, Marshall W. Huston
, et al.
·
Molecular Therapy
·
23
PDF
ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates
2015
·
Thomas Wechsler
, Kathleen E. Meyer
, et al.
·
Blood
·
5
ZFN-mediated genome editing of albumin “safe harbor” in vivo results in supraphysiological levels of human IDS, IDUA and GBA in mice
2015
·
Russell DeKelver
, Michelle Rohde
, et al.
·
Molecular Genetics and Metabolism
·
3
479. ZFN-Mediated In Vivo Genome Editing Results in Supraphysiological Levels of Lysosomal Enzymes Deficient in Hunter and Hurler Syndrome and Gaucher Disease
2015
·
Thomas Wechsler
, Russel DeKelver
, et al.
·
Molecular Therapy
·
2
PDF
ZFN-mediated in vivo genome editing of hepatocytes results in phenotypic correction in murine MPS I and MPS II models
2018
·
Thomas Wechsler
, Russell DeKelver
, et al.
·
Molecular Genetics and Metabolism
·
1
Liver-based expression of the human alpha-galactosidase A gene in a murine Fabry model results in continuous therapeutic levels of enzyme activity and effective substrate reduction
2018
·
Marshall W. Huston
, Makiko Yasuda
, et al.
·
Molecular Genetics and Metabolism
·
1
ZFN-mediated in vivo genome editing results in therapeutic levels of α-galactosidase A and effective substrate reduction in Fabry knockout mice
2018
·
Silvere Pagant
, Marshall W. Huston
, et al.
·
Molecular Genetics and Metabolism
·
1
Liver-based expression of the human alpha-galactosidase A gene (GLA) in a murine Fabry model results in continuous supra-physiological enzyme activity and effective substrate reduction
2017
·
Marshall W. Huston
, Makiko Yasuda
, et al.
·
Molecular Genetics and Metabolism
·
1
ZFN-mediated in vivo genome editing results in phenotypic correction in murine MPS I and MPS II models
2017
·
Russell DeKelver
, Li Ou
, et al.
·
Molecular Genetics and Metabolism
·
1
484. In Vivo Zinc-Finger Nuclease Mediated Iduronate-2-Sulfatase (IDS) Target Gene Insertion and Correction of Metabolic Disease in a Mouse Model of Mucopolysaccharidosis Type II (MPS II)
2016
·
Kanut Laoharawee
, Russell DeKelver
, et al.
·
Molecular Therapy
·
1
PDF
485. ZFN-Mediated Liver-Targeting Gene Therapy Corrects Systemic and Neurological Disease of Mucopolysaccharidosis Type I
2016
·
Li Ou
, Russell DeKelver
, et al.
·
Molecular Therapy
·
1
PDF
ZFN-mediated correction of murine MPS I model by expression of the human IDUA cDNA from the albumin “safe harbor” locus
2016
·
Li Ou
, Russell DeKelver
, et al.
·
Molecular Genetics and Metabolism
·
1
Abstract 3071: Accurate and sensitive detection of KRAS mutations in heterogeneous cancer specimens
2011
·
Yun Bao
, David Merrill
, et al.
·
Cancer Research
·
1
ZFN-mediated in vivo genome editing results in supraphysiological levels of human iduronate 2-sulfatase and phenotypic correction in a murine MPS II model
2016
·
Russell DeKelver
, Kanut Laoharawee
, et al.
·
Molecular Genetics and Metabolism
Abstract 5609: Mechanisms of acquired resistance to selective PI3K inhibitors in breast cancer cell lines
2012
·
Carol Lynn O'Brien
, Jill Spoerke
, et al.
·
Cancer Research
Show more works
View as search
Works count:
19
Citation count:
604
H-index:
5
I10-index:
5
Year
Topic
Type